Closing the Gaps in NSCLC

What treatments and technologies are on the horizon for our patients with non-small cell lung cancer? Joining Mario Nacinovich to give us a look at what’s ahead is Dr. Gregory Kubicek, staff radiation oncologist at the MD Anderson Cooper Cancer Center.

Take a deep dive into the data from a recent clinical trial exploring next generation sequencing in lung squamous cell carcinoma with Dr. Jacob Sands, a thoracic medical oncologist at the Dana-Farber Cancer Institute and an Instructor of Medicine at Harvard Medical School.

Take a deep dive into the data from a recent clinical trial exploring next generation sequencing in lung squamous cell carcinoma with Dr. Jacob Sands, a thoracic medical oncologist at the Dana-Farber Cancer Institute and an Instructor of Medicine at Harvard Medical School.

Armed with encouraging data from clinical trials, thoracic medical oncologist Dr. Jacob Sands walks us through the lung cancer screening technology that has the potential to save about 48,000 lives per year.

From an extensive database to a multidisciplinary team, thoracic medical oncologist Dr. Jacob Sands walks us through the essential components of a lung cancer screening program.

When treating patients with non-small cell lung cancer, their physical, mental, and emotional health need to be considered. That’s why Dr. Jonathan Riess, Associate Professor of Oncology and Hematology at the UC Davis Medical Center, is here to explain how he approaches caring for patients with non-small cell lung cancer.

After beginning treatment for non-small cell lung cancer, it’s important to think about how a patient's body reacts. Tune in as Associate Professor of Oncology and Hematology at the UC Davis Medical Center Dr. Jonathan Riess discusses his top-of-mind considerations for managing toxicities throughout the care course as well as which members of the multidisciplinary care team are important to managing this.

Although a lung cancer diagnosis can take a heavy toll on a patient’s mental and emotional well-being, there are counseling strategies you can use to better communicate with your patients and to ease their fears. Here to share the strategies he uses to help his patients cope with a lung cancer diagnosis is Dr. Jacob Sands, a thoracic medical oncologist at the Dana-Farber Cancer Institute and an Instructor of Medicine at Harvard Medical School.

Armed with encouraging data from clinical trials, thoracic medical oncologist Dr. Jacob Sands walks us through the lung cancer screening technology that has the potential to save about 48,000 lives per year.

From an extensive database to a multidisciplinary team, thoracic medical oncologist Dr. Jacob Sands walks us through the essential components of a lung cancer screening program.